Utilization of human induced pluripotent stem cell-derived cardiomyocytes on an MEA platform for prediction of liabilities with chronic drug treatment

Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Christopher J. Strock
Source: Journal of Pharmacological and Toxicological Methods - Category: Drugs & Pharmacology Source Type: research